0000899243-21-037904.txt : 20210927 0000899243-21-037904.hdr.sgml : 20210927 20210927212638 ACCESSION NUMBER: 0000899243-21-037904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210923 FILED AS OF DATE: 20210927 DATE AS OF CHANGE: 20210927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Naydenov Jordan G CENTRAL INDEX KEY: 0001469618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 211283347 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-23 0 0001175680 CytoDyn Inc. CYDY 0001469618 Naydenov Jordan G 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 1 0 0 0 Common Stock 2021-09-23 4 M 0 888888 0.45 A 7590211 D Common Stock 2021-09-23 4 M 0 133332 0.75 A 7723543 D Common Stock 2021-09-23 4 M 0 266668 0.75 A 7990211 D Warrant (Right to Buy) 0.45 2021-09-23 4 D 0 444444 D 2019-12-13 2024-12-13 Common Stock 444444 0 D Warrant (Right to Buy) 0.75 2021-09-23 4 D 0 66666 D 2017-07-26 2022-07-26 Common Stock 66666 0 D Warrant (Right to Buy) 0.75 2021-09-23 4 D 0 133334 D 2018-01-31 2023-01-31 Common Stock 133334 0 D Warrant (Right to Buy) 0.45 2021-09-23 4 A 0 888888 A 2021-09-23 2024-12-13 Common Stock 888888 888888 D Warrant (Right to Buy) 0.75 2021-09-23 4 A 0 133332 A 2021-09-23 2022-07-26 Common Stock 133332 133332 D Warrant (Right to Buy) 0.75 2021-09-23 4 A 0 266668 A 2021-09-23 2023-01-31 Common Stock 266668 266668 D Warrant (Right to Buy) 0.45 2021-09-23 4 M 0 888888 D 2021-09-23 2024-12-13 Common Stock 888888 0 D Warrant (Right to Buy) 0.75 2021-09-23 4 M 0 133332 D 2021-09-23 2022-07-26 Common Stock 133332 0 D Warrant (Right to Buy) 0.75 2021-09-23 4 M 0 266668 D 2021-09-23 2023-01-31 Common Stock 266668 0 D On September 23, 2021, as an inducement to exercise, the Issuer and the Reporting Person agreed to amend three warrants held by the Reporting Person (the "Warrants") to purchase a total of 644,444 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), pursuant to which twice as many shares could be purchased for double the total original exercise price. By: /s/ Michael D. Mulholland, Attorney-in-fact 2021-09-27